CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection (Q39030321)

8 September 2017

title

CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection (English)

1 reference

8 September 2017

Jo Van Damme

6

0 references

Sofie Struyf

object named as

Sofie Struyf

2

0 references

Dominique Schols

object named as

Dominique Schols

5

0 references

Mieke Gouwy

object named as

Mieke Gouwy

1

0 references

author name string

Nele Berghmans

3

1 reference

8 September 2017

Christophe Vanormelingen

4

1 reference

8 September 2017

language of work or name

English

0 references

publication date

7 March 2011

1 reference

European Journal of Immunology

8 September 2017

published in

1 reference

8 September 2017

volume

41

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

963-973

1 reference

HIV chemokine receptor inhibitors as novel anti-HIV drugs

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Regulation of chemokine activity by posttranslational modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Synergy in cytokine and chemokine networks amplifies the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Therapeutic targeting of chemokine interactions in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CXCR4-CCR5: a couple modulating T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CCR5 ligands modulate CXCL12-induced chemotaxis, adhesion, and Akt phosphorylation of human cord blood CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Chemokine receptor internalization and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041178

7 January 2021

Identifiers

DOI

10.1002/EJI.201041178

1 reference

8 September 2017

1 reference